VOYA Investment Management’s Stoke Therapeutics STOK Stock Holding History
Bought
Maintained
Sold
Other funds holding STOK
RI
LCM
RG
BBA
BI
VOYA Investment Management's STOK Position: Q1 2026 in Review
VOYA Investment Management increased its Stoke Therapeutics (STOK) stake by 5.7% in Q1 2026, buying an estimated $14.6K and bringing the position to 8,205 shares worth $267K. The position accounts for ﹤0.01% of the portfolio, ranked #1998.
VOYA Investment Management first reported a position in STOK in Q2 2020 and has held it in 16 quarters since. The position peaked at $4.59M in Q3 2020. 196 funds tracked by Wall St. Rank hold STOK as of Q1 2026.
- VOYA Investment Management held 8,205 shares of Stoke Therapeutics worth $267K as of Q1 2026.
- VOYA Investment Management bought 444 Stoke Therapeutics shares in Q1 2026, an estimated $14.6K.
- Stoke Therapeutics made up ﹤0.01% of VOYA Investment Management's portfolio in Q1 2026, its #1998 holding.
- VOYA Investment Management first reported a position in Stoke Therapeutics in Q2 2020 and has held it in 16 quarters since.
- VOYA Investment Management's Stoke Therapeutics position peaked at $4.59M in Q3 2020.
- 196 funds tracked by Wall St. Rank held Stoke Therapeutics as of Q1 2026.
Based on VOYA Investment Management's 13F filing for Q1 2026, filed 12 May 2026.